Manufacturers Life Insurance Company, The Tg Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $100 Billion
- Q1 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 81,125 shares of TGTX stock, worth $2.72 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,125
Previous 75,327
7.7%
Holding current value
$2.72 Million
Previous $2.27 Million
41.07%
% of portfolio
0.0%
Previous 0.0%
Shares
35 transactions
Others Institutions Holding TGTX
# of Institutions
415Shares Held
88.1MCall Options Held
2.34MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA15.6MShares$524 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$383 Million0.0% of portfolio
-
State Street Corp Boston, MA7.43MShares$250 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.28MShares$110 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.85MShares$95.6 Million9.29% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.88B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...